Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

956 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial.
Panahi Y, Saadat A, Beiraghdar F, Sahebkar A. Panahi Y, et al. Among authors: sahebkar a. Phytother Res. 2014 Oct;28(10):1461-7. doi: 10.1002/ptr.5149. Epub 2014 Mar 19. Phytother Res. 2014. PMID: 24648302 Clinical Trial.
Eighty subjects with solid tumors who were under standard chemotherapy regimens were randomly assigned to a bioavailability-boosted curcuminoids preparation (180 mg/day; n=40) or matched placebo (n=40) for a period of 8weeks. ...Adjuvant therapy with a bioava …
Eighty subjects with solid tumors who were under standard chemotherapy regimens were randomly assigned to a bioavailability-boosted c …
Effect of supplementation with selenium on postpartum depression: a randomized double-blind placebo-controlled trial.
Mokhber N, Namjoo M, Tara F, Boskabadi H, Rayman MP, Ghayour-Mobarhan M, Sahebkar A, Majdi MR, Tavallaie S, Azimi-Nezhad M, Shakeri MT, Nematy M, Oladi M, Mohammadi M, Ferns G. Mokhber N, et al. Among authors: sahebkar a. J Matern Fetal Neonatal Med. 2011 Jan;24(1):104-8. doi: 10.3109/14767058.2010.482598. Epub 2010 Jun 8. J Matern Fetal Neonatal Med. 2011. PMID: 20528216 Clinical Trial.
DESIGN: A total of 166 primigravid pregnant women in the first trimester of pregnancy, were randomized to receive 100mug of selenium (n = 83) or a placebo (n = 83) per day until delivery. ...Selenium supplementation was associated with a significant increase …
DESIGN: A total of 166 primigravid pregnant women in the first trimester of pregnancy, were randomized to receive 100mug of selenium …
Prooxidant-antioxidant balance in pregnancy: a randomized double-blind placebo-controlled trial of selenium supplementation.
Tara F, Rayman MP, Boskabadi H, Ghayour-Mobarhan M, Sahebkar A, Alamdari DH, Razavi BS, Tavallaie S, Azimi-Nezhad M, Shakeri MT, Oladi M, Yazarlu O, Ouladan S, Sangani MT, Omran FR, Ferns G. Tara F, et al. Among authors: sahebkar a. J Perinat Med. 2010 Sep;38(5):473-8. doi: 10.1515/jpm.2010.068. J Perinat Med. 2010. PMID: 20629489 Clinical Trial.
OBJECTIVE: We assessed the impact of selenium, a trace element with antioxidant properties on a simple measure of oxidative stress in pregnant women. STUDY DESIGN: A novel assay of prooxidant-antioxidant balance (PAB) was applied in a double-blind, pla …
OBJECTIVE: We assessed the impact of selenium, a trace element with antioxidant properties on a simple measure of oxidative st …
Selenium supplementation and the incidence of preeclampsia in pregnant Iranian women: a randomized, double-blind, placebo-controlled pilot trial.
Tara F, Maamouri G, Rayman MP, Ghayour-Mobarhan M, Sahebkar A, Yazarlu O, Ouladan S, Tavallaie S, Azimi-Nezhad M, Shakeri MT, Boskabadi H, Oladi M, Sangani MT, Razavi BS, Ferns G. Tara F, et al. Among authors: sahebkar a. Taiwan J Obstet Gynecol. 2010 Jun;49(2):181-7. doi: 10.1016/S1028-4559(10)60038-1. Taiwan J Obstet Gynecol. 2010. PMID: 20708525 Clinical Trial.
DESIGN: We carried out a randomized, double-blind, placebo-controlled pilot trial. A total of 166 primigravid pregnant women, who were in the first trimester of pregnancy, were randomized to receive 100 microg of selenium (n = 83; dropouts, n = 22) or a place …
DESIGN: We carried out a randomized, double-blind, placebo-controlled pilot trial. A total of 166 primigravid pregnant women, …
Simvastatin treatment reduces heat shock protein 60, 65, and 70 antibody titers in dyslipidemic patients: A randomized, double-blind, placebo-controlled, cross-over trial.
Moohebati M, Bidmeshgi S, Azarpazhooh MR, Daloee MH, Ghayour-Mobarhan M, Tavallaie S, Amini M, Momenzadeh A, Sahebkar A, Paydar R, Rahsepar AA, Parizadeh SM, Akhlaghi S, Ferns GA. Moohebati M, et al. Among authors: sahebkar a. Clin Biochem. 2011 Feb;44(2-3):192-7. doi: 10.1016/j.clinbiochem.2010.09.016. Epub 2010 Sep 26. Clin Biochem. 2011. PMID: 20875810 Clinical Trial.
DESIGN AND METHODS: Participants (n=102) were treated with simvastatin (40mg/day), or placebo in a randomized, double-blind, placebo-controlled, cross-over trial. ...
DESIGN AND METHODS: Participants (n=102) were treated with simvastatin (40mg/day), or placebo in a randomized, double-blind, placebo- …
Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial.
Parizadeh SM, Azarpazhooh MR, Moohebati M, Nematy M, Ghayour-Mobarhan M, Tavallaie S, Rahsepar AA, Amini M, Sahebkar A, Mohammadi M, Ferns GA. Parizadeh SM, et al. Among authors: sahebkar a. Lipids. 2011 Apr;46(4):333-40. doi: 10.1007/s11745-010-3517-x. Epub 2011 Jan 5. Lipids. 2011. PMID: 21207250 Clinical Trial.
We aimed to assess the effects of simvastatin on a novel measure of prooxidant-antioxidant balance (PAB) in dyslipidemic patients. ...We treated 102 dyslipidemic individuals with simvastatin, or a placebo in a double-blind, cross-over, placebo-controlled tria …
We aimed to assess the effects of simvastatin on a novel measure of prooxidant-antioxidant balance (PAB) in dyslipidemic patients. .. …
Results of a randomized,open-label,clinical trial investigating the effects of supplementation with Heracleumpersicum extract as an adjunctive therapy for dyslipidemia.
Panahi Y, Pishgoo B, Beiraghdar F, Araghi ZM, Sahebkar A, Abolhasani E. Panahi Y, et al. Among authors: sahebkar a. ScientificWorldJournal. 2011 Mar 7;11:592-601. doi: 10.1100/tsw.2011.43. ScientificWorldJournal. 2011. PMID: 21403978 Free PMC article. Clinical Trial.
In a randomized, open-label, clinical trial, 100 dyslipidemic subjects were randomly assigned to: (1) H. persicum group (n=50, completers=18), receiving H. persicum extract (500 mg/day) + atorvastatin (10 mg/day) for 8 weeks, or (2) atorvastatin group (n=50, completers=34) …
In a randomized, open-label, clinical trial, 100 dyslipidemic subjects were randomly assigned to: (1) H. persicum group (n=50, comple …
Tear total protein analysis in patients with late sulfur mustard-induced ocular complications: a cross-sectional study.
Panahi Y, Eftekhari Milani A, Sahebkar A, Naderi M, Babaei M, Beiraghdar F, Parvin S, Dadjo Y. Panahi Y, et al. Among authors: sahebkar a. Cutan Ocul Toxicol. 2012 Jun;31(2):104-10. doi: 10.3109/15569527.2011.615359. Epub 2011 Sep 29. Cutan Ocul Toxicol. 2012. PMID: 21958134
Efficacy of Aloe vera/olive oil cream versus betamethasone cream for chronic skin lesions following sulfur mustard exposure: a randomized double-blind clinical trial.
Panahi Y, Davoudi SM, Sahebkar A, Beiraghdar F, Dadjo Y, Feizi I, Amirchoopani G, Zamani A. Panahi Y, et al. Among authors: sahebkar a. Cutan Ocul Toxicol. 2012 Jun;31(2):95-103. doi: 10.3109/15569527.2011.614669. Epub 2011 Oct 12. Cutan Ocul Toxicol. 2012. PMID: 21988705 Clinical Trial.
Evaluation of pruritus severity was performed using a pruritic score questionnaire and visual analogue scale (VAS). RESULTS: Both treatments were associated with significant reductions in the frequency of pruritus (p<0.05), burning sensation (p<0.01 and p<0.001 in …
Evaluation of pruritus severity was performed using a pruritic score questionnaire and visual analogue scale (VAS). RESULTS: Both tre …
Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial.
Panahi Y, Sahebkar A, Amiri M, Davoudi SM, Beiraghdar F, Hoseininejad SL, Kolivand M. Panahi Y, et al. Among authors: sahebkar a. Br J Nutr. 2012 Oct;108(7):1272-9. doi: 10.1017/S0007114511006544. Epub 2011 Nov 18. Br J Nutr. 2012. PMID: 22099425 Clinical Trial.
A total of ninety-six male Iranian veterans (age 37-59 years) were randomised to receive either curcumin (1 g/d, n 46) or placebo (n 50) for 4 weeks. ...In conclusion, curcumin may be regarded as a natural, safe, widely available and inexpensive treatment for the ma
A total of ninety-six male Iranian veterans (age 37-59 years) were randomised to receive either curcumin (1 g/d, n 46) or placebo (n
956 results
Jump to page
Feedback